Eljamel Inquiry Wrong Site Surgeries Evidence
Analysis based on 10 articles · First reported Sep 11, 2026 · Last updated Sep 11, 2026
The inquiry concerns a single public health board in Scotland and carries no direct listed-company exposure, so market reaction is expected to be negligible. Any impact would be limited to reputational and regulatory scrutiny of NHS governance and medical indemnity practices rather than traded securities.
A public inquiry before Lord Weir in Edinburgh is examining the clinical practice of former United Kingdom — NHS Tayside consultant neurosurgeon Sam Eljamel. Evidence heard on Friday included an interim advice letter issued by the Royal College of Surgeons of England to United Kingdom — NHS Tayside's medical director in October 2013, which stated that a number of wrong site surgeries had been carried out and raised concerns about Eljamel's approach to pre-operative marking and post-operative care. The letter also said Eljamel acknowledged he may not have been absolutely open with colleagues about the outcomes of wrong level operations, and the review team could not be sure whether he had been open with patients. Professor Frank Smith, chairman of the RCS invited review mechanism, testified that wrong site operations are classified as never events and should never happen, and that the review recommended United Kingdom — NHS Tayside consider whether further action was needed to review Eljamel's spinal surgery cases. Eljamel worked at Ninewells Hospital in Dundee from 1995 until his suspension in December 2013. The inquiry follows concerns raised by patients that he harmed as many as 200 people. The inquiry continues.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard